NEW EXCLUSIVE LICENSE AGREEMENTNew Exclusive License Agreement • July 2nd, 2015 • vTv Therapeutics Inc. • Pharmaceutical preparations • New York
NEW EXCLUSIVE LICENSE AGREEMENT, dated May 14, 2015 (the “Effective Date”), between THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (“Columbia”), and TransTech Pharma, LLC (“Company”).
AGREEMENT CONCERNING GLUCOKINASE ACTIVATOR PROJECT BY AND BETWEEN NOVO NORDISK A/S AND TRANSTECH PHARMA, INC. DATED AS OF FEBRUARY 20, 2007Agreement Concerning Glucokinase • July 2nd, 2015 • vTv Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT CONCERNING GLUCOKINASE ACTIVATOR PROJECT (this “Agreement”) is entered into this 20th day of February, 2007 (the “Effective Date”), by and between Novo Nordisk A/S, a corporation organized under the laws of Denmark, having a business address at Novo Allé, DK-2880 Bagsvaerd, Denmark (“Novo”), and TransTech Pharma, Inc., a corporation organized under the laws of the State of Delaware, having a business address at 4170 Mendenhall Oaks Parkway, High Point, North Carolina 27265, USA (“TransTech”).
